Los efectos de los AgGLP-1 sobre la obesidad, la resistencia insulnica, la inflamacin, la apnea del sueo y otros FRCV posicionan favorablemente a este grupo de frmacos para el tratamiento del sndrome del ovario poliqustico y de la infertilidad asociada a obesidad35
New England Journal of Medicine , 389(6), 514526
That means it is designed to activate GIP, GLP-1, and glucagon receptors, which are involved in appetite signaling, glucose regulation, and energy metabolism
The medication must be taken on an empty stomach with no more than 4 ounces of plain water, and patients must wait at least 30 minutes before consuming food, beverages, or other oral medications
However, the financial equation becomes very challenging if everyone who wants to be a bit leaner starts using these drugs